RUNX1 and hepatocellular carcinoma: In addition, GSK-3β can mediate the efficacy of RUNX1-IT1 on cell proliferation, EMT and cancer stem-like properties in HCC cells (P < 0.05, Supplementary Figs. 8 and 9).